Electrochemical synthesis of self immolative methylene alkoxy carbamate (MAC) to facilitate construction of antibody drug conjugate linkers with alcohol-containing payloads

In the area of targeted drug delivery, the strategy of using Methylene alkoxy carbamate (MAC) as a self-immolative unit in the linker construction for antibody drug conjugate (ADC) has evolved as the most popular approach in recent time research. Reported synthetic routes for MAC linker construction are limited to very few options which often suffer synthetic challenges with diverse sets of alcohol-containing payloads. An alternative concept of constructing MAC linker employing electrochemical decarboxylative coupling strategy has been validated with a wide range of structurally different alcohols including primary, secondary and tertiary analogues, using DMA as a solvent. The model study allows using alcohol as a limiting reactant, extending the opportunity of utilizing different alcohol-containing payloads to conjugate via MAC to construct ADCs.

Authors

Institutions

Publication Details

Journal
Synthesis
Published
2026-04-29
DOI
https://doi.org/10.1055/a-2867-1260
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Electrochemical synthesis of self immolative methylene alkoxy carbamate (MAC) to facilitate construction of antibody drug conjugate linkers with alcohol-containing payloads

Subhendu K. Mohanty, Suvadeep Nath, Manas Bandyopadhyay, Chandrasekha Korapala
Synthesis
HER2/EGFR in Cancer Research
article

Electrochemical synthesis of self immolative methylene alkoxy carbamate (MAC) to facilitate construction of antibody drug conjugate linkers with alcohol-containing payloads

Subhendu K. Mohanty, Suvadeep Nath, Manas Bandyopadhyay, Chandrasekha Korapala
article en

Abstract

In the area of targeted drug delivery, the strategy of using Methylene alkoxy carbamate (MAC) as a self-immolative unit in the linker construction for antibody drug conjugate (ADC) has evolved as the most popular approach in recent time research. Reported synthetic routes for MAC linker construction are limited to very few options which often suffer synthetic challenges with diverse sets of alcohol-containing payloads. An alternative concept of constructing MAC linker employing electrochemical decarboxylative coupling strategy has been validated with a wide range of structurally different alcohols including primary, secondary and tertiary analogues, using DMA as a solvent. The model study allows using alcohol as a limiting reactant, extending the opportunity of utilizing different alcohol-containing payloads to conjugate via MAC to construct ADCs.

Synthesis
Scientific Solutions (United States) (US), Syngene International (India) (IN)
Good health and well-being
Openalex Percentile: Top 9%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.